EC approves Pfizer’s EMBLAVEO for multidrug-resistant infections
The European Commission (EC) has granted marketing authorisation for Pfizer’s EMBLAVEO (aztreonam-avibactam), aimed at treating adults with multidrug-resistant infections where treatment options are limited. This approval is a significant step in combating …